Lisa J Martin1, Olga Melnichouk1, Ella Huszti1, Philip W Connelly1, Carolyn V Greenberg1, Salomon Minkin1, Norman F Boyd2. 1. Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada (LJM, OM, EH, CVG, SM, NFB); Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, Ontario, Canada (PWC); Departments of Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada (PWC). 2. Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada (LJM, OM, EH, CVG, SM, NFB); Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, Ontario, Canada (PWC); Departments of Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada (PWC). boyd@uhnres.utoronto.ca.
Abstract
BACKGROUND: There is strong evidence that breast cancer risk is influenced by environmental factors. Blood lipid and lipoprotein levels are also influenced by environmental factors and are associated with some breast cancer risk factors. We examined whether serial measures of serum lipids and lipoproteins were associated with breast cancer risk. METHODS: We carried out a nested case-control study within a randomized long-term dietary intervention trial with 4690 women with extensive mammographic density followed for an average of 10 years for breast cancer incidence. We measured lipids in an average of 4.2 blood samples for 279 invasive breast cancer case subjects and 558 matched control subjects. We calculated subaverages of lipids for each subject based on menopausal status and use of hormone replacement therapy (HRT) at blood collection and analyzed their association with breast cancer using generalized estimating equations. All statistical tests were two-sided. RESULTS: High-density lipoprotein-cholesterol (HDL-C) (P = .05) and apoA1 (P = .02) levels were positively associated with breast cancer risk (75(th) vs 25(th) percentile: HDL-C, 23% higher; apoA1, 28% higher) and non-HDL-C (P = .03) and apoB (P = .01) levels were negatively associated (75(th) vs 25(th) percentile: non-HDL-C, 19% lower; apoB, 22% lower). These associations were observed only when lipids were measured when HRT was not used. Total cholesterol and triglyceride levels were not statistically significantly associated with breast cancer risk. CONCLUSIONS: These results demonstrate that serum lipids are associated with breast cancer risk in women with extensive mammographic density. The possibility that interventions for heart disease prevention, which aim to reduce non-HDL-C or raise HDL-C, may have effects on breast cancer risk merits examination.
BACKGROUND: There is strong evidence that breast cancer risk is influenced by environmental factors. Blood lipid and lipoprotein levels are also influenced by environmental factors and are associated with some breast cancer risk factors. We examined whether serial measures of serum lipids and lipoproteins were associated with breast cancer risk. METHODS: We carried out a nested case-control study within a randomized long-term dietary intervention trial with 4690 women with extensive mammographic density followed for an average of 10 years for breast cancer incidence. We measured lipids in an average of 4.2 blood samples for 279 invasive breast cancer case subjects and 558 matched control subjects. We calculated subaverages of lipids for each subject based on menopausal status and use of hormone replacement therapy (HRT) at blood collection and analyzed their association with breast cancer using generalized estimating equations. All statistical tests were two-sided. RESULTS: High-density lipoprotein-cholesterol (HDL-C) (P = .05) and apoA1 (P = .02) levels were positively associated with breast cancer risk (75(th) vs 25(th) percentile: HDL-C, 23% higher; apoA1, 28% higher) and non-HDL-C (P = .03) and apoB (P = .01) levels were negatively associated (75(th) vs 25(th) percentile: non-HDL-C, 19% lower; apoB, 22% lower). These associations were observed only when lipids were measured when HRT was not used. Total cholesterol and triglyceride levels were not statistically significantly associated with breast cancer risk. CONCLUSIONS: These results demonstrate that serum lipids are associated with breast cancer risk in women with extensive mammographic density. The possibility that interventions for heart disease prevention, which aim to reduce non-HDL-C or raise HDL-C, may have effects on breast cancer risk merits examination.
Authors: M Ferraroni; M Gerber; A Decarli; S Richardson; E Marubini; P Crastes de Paulet; A Crastes de Paulet; H Pujol Journal: Int J Epidemiol Date: 1993-10 Impact factor: 7.196
Authors: R G Ziegler; R N Hoover; M C Pike; A Hildesheim; A M Nomura; D W West; A H Wu-Williams; L N Kolonel; P L Horn-Ross; J F Rosenthal; M B Hyer Journal: J Natl Cancer Inst Date: 1993-11-17 Impact factor: 13.506
Authors: Shiyama Mudali; Adrian S Dobs; Jingzhong Ding; Jane A Cauley; Moyses Szklo; Sherita Hill Golden Journal: J Clin Endocrinol Metab Date: 2004-11-16 Impact factor: 5.958
Authors: Lisa J Martin; Ella Huszti; Philip W Connelly; Cary V Greenberg; Salomon Minkin; Norman F Boyd Journal: J Natl Cancer Inst Date: 2016-05-18 Impact factor: 13.506
Authors: Paulette D Chandler; Foluso Agboola; Kimmie Ng; Jamil B Scott; Bettina F Drake; Gary G Bennett; Andrew T Chan; Bruce W Hollis; Karen M Emmons; Charles S Fuchs; Edward L Giovannucci Journal: BMC Nutr Date: 2015-12-17
Authors: Sarah A Lucht; A Heather Eliassen; Kimberly A Bertrand; Thomas P Ahern; Signe Borgquist; Bernard Rosner; Susan E Hankinson; Rulla M Tamimi Journal: Cancer Causes Control Date: 2019-07-01 Impact factor: 2.506
Authors: Paulette D Chandler; Yiqing Song; Jennifer Lin; Shumin Zhang; Howard D Sesso; Samia Mora; Edward L Giovannucci; Kathryn E Rexrode; M Vinayaga Moorthy; Chunying Li; Paul M Ridker; I-Min Lee; JoAnn E Manson; Julie E Buring; Lu Wang Journal: Am J Clin Nutr Date: 2016-04-20 Impact factor: 7.045
Authors: Alicia Beeghly-Fadiel; Nikhil K Khankari; Ryan J Delahanty; Xiao-Ou Shu; Yingchang Lu; Marjanka K Schmidt; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Joe Dennis; Drakoulis Yannoukakos; Alison M Dunning; Paul D P Pharoah; Georgia Chenevix-Trench; Roger L Milne; David J Hunter; Hall Per; Peter Kraft; Jacques Simard; Douglas F Easton; Wei Zheng Journal: Int J Epidemiol Date: 2020-08-01 Impact factor: 7.196